Mitophagy in Acute Kidney Injury and Kidney Repair
Open accessThe DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index.
Abstract
Acute kidney injury (AKI) is a major kidney disease characterized by rapid decline of renal function. Besides its acute consequence of high mortality, AKI has recently been recognized as an independent risk factor for chronic kidney disease (CKD). Maladaptive or incomplete repair of renal tubules after severe or episodic AKI leads to renal fibrosis and, eventually, CKD. Recent studies highlight a key role of mitochondrial pathology in AKI development and abnormal kidney repair after AKI. As such, timely elimination of damaged mitochondria in renal tubular cells represents an important quality control mechanism for cell homeostasis and survival during kidney injury and repair. Mitophagy is a selective form of autophagy that selectively removes redundant or damaged mitochondria. Here, we summarize our recent understanding on the molecular mechanisms of mitophagy, discuss the role of mitophagy in AKI development and kidney repair after AKI, and present future research directions and therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Mitochondrial fragmentation and mitophagy induction in proximal tubule cells during renal ischemia–reperfusion injury. (A) Mitochondrial fragmentation was observed in proximal tubule cells immediately after renal ischemia–reperfusion (IR). The fragmentation was remarkably increased in IR kidney. Asterisks indicate elongated (>2 μm) mitochondria [29]. (B) Quantification of mitochondrial fragmentation [29]. (C) Representative TEM images of autophagosomes (pointed to by the arrowhead in the left panel) and a mitophagosome (pointed to by the arrowhead in the right panel) in renal proximal tubule cells after IR [45].](https://figures.cochat.ai/paper-figures/ad660fbeb0a64df88aa52176f0a6da60/mitophagy-in-acute-kidney-injury-and-kidney-repair-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Growing evidence suggests that mitophagy is an important defence mechanism in AKI”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [87]
The cited source says what the claim attributes to it.
In the citing paper
“Mitophagy induction in PTECs might represent a common mechanism for kidney tubular cell protection in various models of AKI.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 2×
“Macroauphagy (hereafter called autophagy) involves the formation f d uble-m mbrane-bound autophagosomes which enclose parts of cytoplasm, and autophag some-lysosome fusion to form an autolys some in whic argoes are deg a d by lysosomal hydrolase, and the degradation products are l for recycling [47,48].”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 2×
“PARK2 is a cytosolic ubiquitin E3 ligase [68].”
BackgroundYoule, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835 · cited 1×
“The ubiquitin-labeled mitochondria are subsequently recognized by autophagy receptor proteins, such as voltage-dependent anion channel 1 (VDAC1) and sequestosome1 (p62/SQSTM1) that link mitochondria to autophagosomes through interacting with LC3 in autophagosome membrane, leading to autophagic engulfment of mitochondr…”
BackgroundThe ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., Sideris, D. P., Fogel, A. I., & Youle, R. J. (2015) · Nature · doi:10.1038/nature14893 · Cited by 2,774 · cited 7×
“BNIP3 and NIX are BH3-only proteins that localize in MOM [73].”
BackgroundInfluentialMitofusin 2 tethers endoplasmic reticulum to mitochondria
de Brito, O. M., & Scorrano, L. (2008) · Nature · doi:10.1038/nature07534 · Cited by 2,442
The machinery of macroautophagy
Feng, Y., He, D., Yao, Z., & Klionsky, D. J. (2014) · Cell Research · doi:10.1038/cr.2013.168 · Cited by 2,083 · cited 2×
“Macroauphagy (hereafter called autophagy) involves the formation f d uble-m mbrane-bound autophagosomes which enclose parts of cytoplasm, and autophag some-lysosome fusion to form an autolys some in whic argoes are deg a d by lysosomal hydrolase, and the degradation products are l for recycling [47,48].”
BackgroundMatsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., Sou, Y.-S., Saiki, S., Kawajiri, S., Sato, F., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910140 · Cited by 1,969 · cited 1×
“Ub was sufficient to recruit autophagy receptors NDP52 and optineurin (OPTN) to induce mitophagy regardless of PARK2 [72].”
BackgroundThe pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900
Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells
Liu, L., Feng, D., Chen, G., Chen, M., Zheng, Q., Song, P., Ma, Q., Zhu, C., Wang, R., Qi, W., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2422 · Cited by 1,684
Cited by
Mitochondrial quality control in kidney injury and repair
Tang, C., Cai, J., Yin, X.-M., Weinberg, J. M., Venkatachalam, M. A., & Dong, Z. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00369-0 · Cited by 513
Self-citationAutophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Self-citationKidney physiology and susceptibility to acute kidney injury: implications for renoprotection
Scholz, H., Boivin, F. J., Schmidt-Ott, K. M., Bachmann, S., Eckardt, K.-U., Scholl, U. I., & Persson, P. B. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00394-7 · Cited by 314
Han, Y.-C., Tang, S.-Q., Liu, Y.-T., Li, A.-M., Zhan, M., Yang, M., Song, N., Zhang, W., Wu, X.-Q., Peng, C.-H., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04184-8 · Cited by 257
Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease
Ho, H.-J., & Shirakawa, H. (2022) · Cells · doi:10.3390/cells12010088 · Cited by 255
Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases
Aranda-Rivera, A. K., Cruz-Gregorio, A., Aparicio-Trejo, O. E., & Pedraza-Chaverri, J. (2021) · Biomolecules · doi:10.3390/biom11081144 · Cited by 226
Mitochondrial dysfunction and the AKI-to-CKD transition
Jiang, M., Bai, M., Lei, J., Xie, Y., Xu, S., Jia, Z., & Zhang, A. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00285.2020 · Cited by 213
Wang, Y., Zhu, J., Liu, Z., Shu, S., Fu, Y., Liu, Y., Cai, J., Tang, C., Liu, Y., Yin, X., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101767 · Cited by 185
Self-citationShe, R., Liu, D., Liao, J., Wang, G., Ge, J., & Mei, Z. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1191629 · Cited by 160
Mitochondria-Associated ER Membranes – The Origin Site of Autophagy
Yang, M., Li, C., Yang, S., Xiao, Y., Xiong, X., Chen, W., Zhao, H., Zhang, Q., Han, Y., & Sun, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00595 · Cited by 154
Shi, Y., Tao, M., Ma, X., Hu, Y., Huang, G., Qiu, A., Zhuang, S., & Liu, N. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2673-z · Cited by 132
Mitochondrial Quality Control in Cerebral Ischemia–Reperfusion Injury
Wu, M., Gu, X., & Ma, Z.-L. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02494-8 · Cited by 119
Mitophagy in the Pathogenesis of Liver Diseases
Ke, P. (2020) · Cells · doi:10.3390/cells9040831 · Cited by 94
“Improper regulation of mitophagy is implied to participate in the pathogenesis of age-related neurodegenerative and cardiovascular diseases [8,9], metabolic syndrome [10], and tissue injury [11,12].”
BackgroundLiu, L., Ning, X., Lei, W., Zhou, Y., Zhao, L., Ma, F., Bai, M., Yang, X., Wang, D., & Sun, S. (2022) · Theranostics · doi:10.7150/thno.71722 · Cited by 97
“Furthermore, high expression of Twist1 was found in the renal tissue and serum of patients with Theranostics 2022, Vol. 12, Issue 8 https://www.thno.org 3773 CKD [14, 26, 45, 46].”
BackgroundInfluentialGuo, J. X., Wang, R., & Liu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639165 · Cited by 97
“Recently, the critical role of mitophagy in the progression of AKI and subsequent kidney repairing has been unveiled (9).”
BackgroundYeh, T.-H., Tu, K.-C., Wang, H., & Chen, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031755 · Cited by 120
“Basically, mitochondrial homeostasis is maintained through three processes: mitochondrial dynamics, mitophagy, and mitochondrial biogenesis [156].”
BackgroundTahir, I., & Alkheraije, K. A. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1149720 · Cited by 111
Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis
Niculae, A., Gherghina, M.-E., Peride, I., Ţigliş, M., Nechita, A.-M., & Checheriţă, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814019 · Cited by 101
Mitochondrial dysfunction and oxidative stress: Role in chronic kidney disease
Srivastava, A., Tomar, B., Sharma, D., & Rath, S. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121432 · Cited by 93
Adenine-induced animal model of chronic kidney disease: current applications and future perspectives
Yang, Q., Su, S., Luo, N., & Cao, G. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2336128 · Cited by 103
“…connected with programmed renal cell death, including apoptosis, necroptosis, ferroptosis, pyroptosis, and autophagy, as is now recognized [170–176]. in rodent models of adenine-induced nephropathy, where crystal deposition and tubular injury are predominantly observed in the proximal…”
BackgroundLiu, B., Cao, Y., Wang, D., Zhou, Y., Zhang, P., Wu, J., Chen, J., Qiu, J., & Zhou, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.777670 · Cited by 77
“In 2017, 1.2 million people died from chronic kidney disease (CKD), and the global all-age mortality rate of CKD increased by 41.5% within the last 28 years (Global, 2020).”
BackgroundInfluentialAutophagy: a double-edged sword in ischemia–reperfusion injury
Tang, L., Zhang, W., Yan, L., Wang, W., Deng, X., Wang, C., & Shi, W. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00713-x · Cited by 96
Mitochondrial Dysfunction in Kidney Disease and Uremic Sarcopenia
Takemura, K., Nishi, H., & Inagi, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.565023 · Cited by 72
“The mutation of Drp1 is associated with lethal neonatal defects in humans (Waterham et al., 2007), and the mice deficient in Drp1 are also embryonic lethal, whereas brain-specific Drp1 ablation causes developmental defects to the cerebellum (Wakabayashi et al., 2009).”
BackgroundMitochondrial Dysfunction: The Silent Catalyst of Kidney Disease Progression
Pavlović, N., Križanac, M., Kumrić, M., Vukojević, K., & Božić, J. (2025) · Cells · doi:10.3390/cells14110794 · Cited by 80
“In CKD, ongoing mitochondrial dysfunction contributes to renal fibrosis through metabolic reprogramming, persistent oxidative stress, and damage to mitochondrial DNA (mtDNA), particularly in diabetes and IgA nephropathy [19,26,55,56].”
SS‐31, a Mitochondria‐Targeting Peptide, Ameliorates Kidney Disease
Zhu, Y., Luo, M., Bai, X., Li, J., Nie, P., Li, B., & Luo, P. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1295509 · Cited by 79
“Studies have revealed that abnormal or defective mitophagy is central to the pathophysiology of several kidney diseases and that the activation of mitophagy is a protective mechanism against kidney disease [99].”
BackgroundMechanisms and Functions of Mitophagy and Potential Roles in Renal Disease
Zuo, Z., Jing, K., Wu, H.-L., Wang, S., Ye, L., Li, Z., Yang, C., Pan, Q., Liu, W. J., & Liu, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00935 · Cited by 65
Li, Z., Liu, Z., Luo, M.-N., Li, X., Chen, H., Gong, S., Zhang, Y., Zhang, Y., Liu, H., & Li, X. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01034-0 · Cited by 62
Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases
Li, X., Huang, L., Lan, J., Feng, X., Li, P., Wu, L., & Peng, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105240 · Cited by 57
Gao, P., Yang, W., & Sun, L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3120539 · Cited by 67
“Additionally, timely initiation of mitophagy represents an important quality control mechanism for cellular survival and repair during acute kidney injury (AKI) [101].”
BackgroundMitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities
Zhang, P., Zhou, M., Guo, J., Zheng, H., Tang, J., Zhang, C., Liu, Y., Liu, W. J., & Wang, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/1010268 · Cited by 61
“As part of a healthy network of mitochondria, mitophagy is regulated by a PINK1-PARKIN pathway for mitochondrial identification and labeling [88].”
BackgroundSelf-citationThe Effect of Polyphenols on Kidney Disease: Targeting Mitochondria
Ashkar, F., Bhullar, K. S., & Wu, J. (2022) · Nutrients · doi:10.3390/nu14153115 · Cited by 70
Gao, X., Yin, Y., Liu, S., Dong, K., Wang, J., & Guo, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125541 · Cited by 51
Zheng, T., Wang, H., Chen, Y., Chen, X., Wu, Z., Hu, Q.-Y., & Sun, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.897046 · Cited by 57
Song, M., Zhou, Y., & Fan, X. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02795-6 · Cited by 47
Oxyberberine Prevented Lipopolysaccharide‐Induced Acute Lung Injury through Inhibition of Mitophagy
Zhao, R., Wang, B., Wang, D., Wu, B., Ji, P.-Y., & Tan, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6675264 · Cited by 46
“There are accumulating data showing that mitophagy was increased in acute heart damage [34], acute kidney damage [35], and acute lung injury [36].”
BackgroundParicalcitol Attenuates Contrast-Induced Acute Kidney Injury by Regulating Mitophagy and Senescence
Bae, E., Kim, J. H., Jung, M. H., Jang, S. J., Lee, T. W., Jung, S., Lee, S., Jang, H. N., Chang, S., & Park, D. J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7627934 · Cited by 39
“Mitophagy modulates cell apoptosis [6] and ROS removal, eliminates damaged mitochondria, relieves inflammatory responses [7], and inhibits NLRP3 inflammasome activation in AKI [8, 9].”
BackgroundPannexin 1 targets mitophagy to mediate renal ischemia/reperfusion injury
Su, L., Zhang, J., Wang, J., Wang, X., Cao, E. Z., Yang, C., Sun, Q., Ramadoss, S., & Peng, Z. (2023) · Communications Biology · doi:10.1038/s42003-023-05226-x · Cited by 41
New insights into muscle function in chronic kidney disease and metabolic acidosis
Chalupsky, M., Goodson, D. A., Gamboa, J. L., & Roshanravan, B. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000700 · Cited by 42
“Left panel adapted from [85], modified to illustrate the end result of smaller, fragmented mitochondria, right panel previously published [12&].”
MethodAutophagy in Cisplatin Nephrotoxicity during Cancer Therapy
Hu, X., Ma, Z., Wen, L., Li, S., & Dong, Z. (2021) · Cancers · doi:10.3390/cancers13225618 · Cited by 38
Self-citationMetabolic mechanisms of acute proximal tubular injury
Hall, A. M., & de Seigneux, S. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02701-y · Cited by 40
“Moreover, the energetic crisis of AKI triggers organelle degradation by autophagy, and enhancing the specific removal of damaged mitochondria (mitophagy) might help to limit oxidative stress [118].”
BackgroundQin, S., Liu, C., Chen, Y., Yao, M., Liao, S., Xin, W., Gong, S., Guan, X., Li, Y., Xiong, J., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.01.025 · Cited by 43
Li, S., He, X., Ruan, L., Ye, T., Wen, Y., Song, Z., Hu, S., Chen, Y., Peng, B., & Li, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.804685 · Cited by 41
Ji, H., Zhao, Y., Ma, X., Wu, L., Guo, F., Huang, F., Song, Y., Wang, J., & Qin, G. (2023) · Inflammation · doi:10.1007/s10753-023-01940-0 · Cited by 37
“Mitophagy is a specific form of autophagy that removes defective or damaged mitochondria [25].”
Autophagy and Mitophagy in Diabetic Kidney Disease—A Literature Review
Stăniguț, A. M., Tuta, L. A., Pana, C., Alexandrescu, L., Suceveanu, A. P., Blebea, N. M., & Văcăroiu, I. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020806 · Cited by 42
“Mitophagy is an adaptive or defense mechanism for maintaining a population of healthy mitochondria and ensuring cell survival [25].”
InfluentialLiu, J.-X., Yang, C., Liu, Z.-J., Su, H.-Y., Zhang, W., Pan, Q., & Liu, J. (2020) · Aging · doi:10.18632/aging.103726 · Cited by 37
Recent advances in engineered nanomaterials for acute kidney injury theranostics
Wang, L., Zhang, Y., Li, Y., Chen, J., & Lin, W. (2020) · Nano Research · doi:10.1007/s12274-020-3067-3 · Cited by 32
Lei, J., Xie, Y., Sheng, J., & Song, J. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2056054 · Cited by 35
The Mitochondrion: A Promising Target for Kidney Disease
Tanrıöver, C., Çöpür, S., Uçku, D., Cakir, A. B., Hasbal, N. B., Soler, M. J., & Kanbay, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020570 · Cited by 32
Li, Q., Ming, Y., Jia, H., & Wang, G. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9720 · Cited by 29
Li, Y., Lin, R., Peng, X., Wang, X., Liu, X., Li, L., Bai, R., Wen, S., Ruan, Y., Chang, X., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3659278 · Cited by 29
“Mitophagy has also been found to play an important role in the progression of several diseases, such as Parkinson ’ s disease (PD), diabetic kidney disease, and MIRI [112 – 115].”
Liu, P., Hu, P., Jin, M., Sun, W., Wu, J., Tang, Y., Shi, D., Xie, T., Tong, Y., Huang, L., et al. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04012-5 · Cited by 31
Yao, M., Qin, S., Xiong, J., Xin, W., Guan, X., Gong, S., Chen, J., Liu, Y., Zhang, B., Zhao, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935937 · Cited by 27
“The kidney is a human organ with the second highest mitochondrial abundance, which plays a vital role in maintaining kidney health (Wang et al., 2020).”
BackgroundLasmiditan promotes recovery from acute kidney injury through induction of mitochondrial biogenesis
Hurtado, K. A., Janda, J., & Schnellmann, R. G. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00249.2022 · Cited by 28
Natural products for kidney disease treatment: Focus on targeting mitochondrial dysfunction
Huang, J., Liang, Y., & Zhou, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1142001 · Cited by 34
Mitophagy: A Novel Therapeutic Target for Treating DN
Yang, M., Li, C., Yang, S., Xiao, Y., Chen, W., Gao, P., Jiang, N., Xiong, S., Wei, L., Zhang, Q., et al. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666201006152656 · Cited by 27
Li, J., Li, T., Li, Z., Song, Z., & Gong, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1154743 · Cited by 28
Matsushita, K., Toyoda, T., Yamada, T., Morikawa, T., & Ogawa, K. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4069 · Cited by 23
Mitophagy Promotes Hair Regeneration by Activating Glutathione Metabolism
Wang, D., Jiang, J., Wang, M., Li, K., Liang, H., Wang, N., Liu, W., Wang, M., Zhou, S., Zhang, M., et al. (2024) · Research · doi:10.34133/research.0433 · Cited by 34
“Timely self-elimination of damaged mitochondria from cells through mitophagy is an important quality control mechanism for cell homeostasis and survival during injury and repair [42].”
BackgroundTan, R., Xie, K.-H., Yuan, L., Lin, X., Zhu, B., Tong-tong, L., & Wang, L. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.10.001 · Cited by 22
Microcystin-LR-Exposure-Induced Kidney Damage by Inhibiting MKK6-Mediated Mitophagy in Mice
Yao, X., Liu, Y., Yang, Y., Li, Y., Hu, N., Song, F., & Yang, F. (2023) · Toxins · doi:10.3390/toxins15060404 · Cited by 22
Nakamura, E., Aoki, T., Endo, Y., Kazmi, J. S., Hagiwara, J., Kuschner, C. E., Yin, T., Kim, J. H., Becker, L. B., & Hayashida, K. (2024) · Life · doi:10.3390/life14040477 · Cited by 31
“Research using knockout mice for BNIP3 and PINK1, two key regulators of mitophagy, has illuminated the protective effects of this process [125–128].”
BackgroundMitochondrial Oxidative Metabolism: An Emerging Therapeutic Target to Improve CKD Outcomes
Mapuskar, K. A., Vasquez-Martinez, G., Andrade, G. M., Tomanek‐Chalkley, A., Zepeda‐Orozco, D., & Allen, B. G. (2023) · Biomedicines · doi:10.3390/biomedicines11061573 · Cited by 23
Gu, H., Li, J., & Ni, Y. (2023) · Environmental Toxicology · doi:10.1002/tox.23890 · Cited by 21
Wang, X., Luo, T., Yang, L., Yang, L., Liu, M., Zou, Q., Wang, D., Yang, C.-R., Xue, Q., Liu, S., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.012 · Cited by 19
Small molecules as a source for acute kidney injury therapy
Feng, Y., Yang, Y., & Chen, H. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108169 · Cited by 19
Relationship between ferroptosis and mitophagy in renal fibrosis: a systematic review
Zhang, M., Tong, Z., Wang, Y., Fu, W., Meng, Y., Huang, J., & Sun, L. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2250574 · Cited by 20
Self-citationSerotonin regulation of mitochondria in kidney diseases
Hurtado, K. A., Scholpa, N. E., Schnellmann, J. G., & Schnellmann, R. G. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107154 · Cited by 22
“…mitophagy and ubiquitination-dependent mitophagy, there have been reports of mitophagy independent of these mechanisms such as BCL2 interacting protein 3 (BNIP3), BNIP3-like (BNIP3L/ NIX), and FUN14 domain containing 1 (FUNDC1) mediated mitophagy and optineurin dependent mitophagy [84–87].”
Zhou, L., Yan, J., Cui, C., Xu, Y., Zhang, K., Du, M., Zhang, Z., Wu, X., & Li, B. (2025) · Small Structures · doi:10.1002/sstr.202500195 · Cited by 24
The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis
Miranda‐Díaz, A. G., Echavarría, R., Cardona-Muñóz, E. G., Ortiz‐Lazareno, P. C., Sierra, J. A., Gómez-Hermosillo, L. F., Casillas-Moreno, J., Campos-Bayardo, T. I., Román-Rojas, D., & García-Sánchez, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015234 · Cited by 17
“AmtDNA and AmtRNA can help predict the risk of kidney damage in patients with SLE (Figure 4) [145].”
BackgroundPathophysiological role of calcium channels and transporters in the multiple myeloma
Li, T., Chen, J., & Zeng, Z. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00781-4 · Cited by 18
Packialakshmi, B., Stewart, I. J., Burmeister, D. M., Feng, Y., McDaniel, D. P., Chung, K. K., & Zhou, X. (2022) · Physiological Reports · doi:10.14814/phy2.15181 · Cited by 22
Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies
Jia, L., Yang, Y., Sun, F., Tao, H., Lu, C., & Yang, J. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111035 · Cited by 16
Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury
Pan, H., Chen, Y., Fang, W.-C., Wu, V., & Sun, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169318 · Cited by 15
Wu, Q., Yan, R., Yang, H., Wang, Y., Zhang, C., Zhang, J., Cui, Z., Wang, Y., & Weiwei, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.992597 · Cited by 17
Self-citationPan, C., Zhao, H., Cai, X., Wu, M., Qin, B., & Li, J. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2379601 · Cited by 17
“Several studies have demonstrated the cytoprotective role of mito-phagy in renal iRi [84–86]. tang c, et al. reported that the deficiency of Pink1 and Park2 led to more severe mitochondrial damage, ROS accumulation and inflammatory responses, emphasizing the significance of mitophagy in maintaining…”
BackgroundYu, S., Palanisamy, K., Sun, K., Li, X., Wang, Y., Lin, F., Chen, K., Wang, I., Yu, T., & Li, C. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16301 · Cited by 14
Self-citationPham, J. H., & Stankowska, D. L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1198343 · Cited by 14
Liang, J., Qiu, Y., Fu, T., Li, J., Yang, J., & Tong, Y. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s574758 · Cited by 13
“53,54 Among microbiota-derived metabolites, SCFAs—notably butyrate—exert protective effects on renal mitochondria by promoting mitochondrial biogenesis, maintaining redox homeostasis, and mitigating urate-induced cytotoxicity.”
Ox‐LDL aggravates contrast‐induced injury of renal tubular epithelial cells
Yang, D., Yang, X., Chen, S., Lv, M., Tan, J., & Yang, D. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23379 · Cited by 12
Song, Z., Li, J., & Gong, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156416 · Cited by 12
Wei, S., Fu, Y., Zeng, Y., Wu, W., Cai, J., & Dong, Z. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108930 · Cited by 16
Self-citationNakashima, M., Suga, N., Ikeda, Y., Yoshikawa, S., & Matsuda, S. (2024) · Biomolecules · doi:10.3390/biom14020207 · Cited by 11
“As renal tissue has massive mitochondrial content, mitophagy and/or mitochondrial biogenesis may be critical to overwhelming stressful illnesses, including AKI [42,43].”
BackgroundCalorie Restriction Provides Kidney Ischemic Tolerance in Senescence-Accelerated OXYS Rats
Andrianova, N. V., Zorova, L. D., Pevzner, I. B., Kolosova, N. G., Plotnikov, E. Y., & Zorov, D. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315224 · Cited by 12
Liao, P., Wang, X., Dong, H. Y., Chai, D., Yue, Z., & Lyu, L. (2023) · Shock · doi:10.1097/shk.0000000000002160 · Cited by 11
Hurtado, K. A., & Schnellmann, R. G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1344075 · Cited by 14
Chen, J., Chen, C., Lv, C., Feng, R., Zhong, W., Liu, Y., Zhou, S., & Zhao, M. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2463572 · Cited by 14
Ortega-Hernández, N., Ortega-Romero, M., Medeiros-Domingo, M., Barbier, O. C., & Rojas‐López, M. (2022) · Analytical Letters · doi:10.1080/00032719.2022.2053982 · Cited by 9
Relationship between ferroptosis and mitophagy in acute lung injury: a mini-review
Cheng, Y., Zhu, L., Xie, S., Lu, B., Du, X., Ding, G., Wang, Y., Ma, L., & Li, Q. (2024) · PeerJ · doi:10.7717/peerj.18062 · Cited by 12
Self-citationYe, Q., Chen, H., Ma, H., Xiang, X., Hu, S., Xia, C., & Fu, L. (2021) · BioMed Research International · doi:10.1155/2021/9963732 · Cited by 10
“AKI: Acute kidney injury XXD: Xiaoyu Xiezhuo Drink UHPLC-Q-TOF-MS: Ultra-high-performance liquid chro- matography coupled with hybrid triple quadrupole time-of-flight mass spectrometry PPI: Protein-protein interaction I/R: Ischemia-reperfusion ARF: Acute renal failure GFR: Glomerular filtration rate CKD: Chronic kidne…”
BackgroundInfluentialMitophagy stimulation as a novel strategy for the treatment of mitochondrial diseases
Lee, K., & Yun, J. (2022) · Journal of genetic medicine · doi:10.5734/jgm.2022.19.2.49 · Cited by 9
Targeting mitochondrial dysfunction: an innovative strategy for treating renal fibrosis
Wu, Y.-J., Yang, Y., Yan, Y.-L., Yang, H.-Y., & Du, J. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05297-w · Cited by 11
“On the other hand, there are independent non-ubiquitin-dependent mechanisms regulated by mitotic receptors on the mitochondrial outer membrane, including Bcl-2/adenovirus E1B interaction protein 3 (BNIP3), NIX, and the FUN14 domain containing protein 1 (FUNDC1) [25].”
Nosoko, M., Matsuda, H., Ikeda, J., Abe, M., Masuhiro, Y., Endo, M., Hamet, P., & Tremblay, J. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00026.2024 · Cited by 9
Mitochondrial quality control in acute kidney disease
Sheng, J., Li, X., Lei, J., Gan, W., & Song, J. (2023) · Journal of Nephrology · doi:10.1007/s40620-023-01582-3 · Cited by 6
“Therefore, immediate removal of damaged mitochondria can control cell homeostasis and survival during kidney injury and repair [48].”
BackgroundLee, H.-J., Kim, Y.-J., Kim, K., Cho, S.-P., Hong, G.-L., & Jung, J. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad094 · Cited by 6
Targeting mitophagy using isoliensinine as a therapeutic strategy for renal cell carcinoma treatment
Wu, M., Chang, Y.-T., Chuang, T.-Y., Ko, W.-S., Lu, C., & Shieh, J. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.037 · Cited by 8
Pérez-Moreno, E., Toledo, T., Campusano, P., Zuñiga, S., Azócar, L., Feuerhake, T., Méndez, G. P., Labarca, M., Pérez-Molina, F., de la Peña, A., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116923 · Cited by 5
Deng, X., Leng, Y., Xiong, Y., Li, W., Wu, C., Yang, Y., Wang, B., Gong, S., Yang, B., Yang, B., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-03515-5 · Cited by 6
Tasić, D., & Dimitrijević, Z. (2024) · Diagnostics · doi:10.3390/diagnostics14182094 · Cited by 8
“This underscores the need for responsible and cautious research practices, including practical pharmacokinetics and the specific accumulation of antioxidants in cells, which is the essence of trials related to the recovery of mitochondrial function [123].”
BackgroundLozano-López, D. A., Hernández‐Ortega, L. D., González‐Mariscal, L., Díaz-Coránguez, M., Pinto-Dueñas, D. C., & Castañeda‐Arellano, R. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04956-9 · Cited by 7
“Mitophagy is a special form of autophagy, in which dysfunctional mitochondria are selectively removed to maintain mitochondrial quality and function [138].”
Garavaglia, C., Ossoli, A., & Gomaraschi, M. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02654-0 · Cited by 5
“…for maintaining mitochondrial integrity under stress conditions [126]; mitophagy selectively removes damaged mitochondria, while mitochondrial biogenesis, primarily regulated by PPARG coactivator 1α (PGC-1α), replenishes mitochondrial content, thus supporting cellular energy demands [127, 128].”
Metadata
- Authors
- Wang, Y., Cai, J., Tang, C., & Dong, Z.
- Affiliations
- Second Xiangya Hospital of Central South University (CN)
- Augusta University (US)
- Corresponding author
- Tang, Chengyuan
- Dong, Zheng
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-02-01
- Volume
- 9
- Issue
- 2
- Pages
- 338
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7072358
- OpenAlex
- W3003245890
- Cited by
- 130
- References
- 132
- Citations by year
- 2026: 7 · 2025: 24 · 2024: 15 · 2023: 25 · 2022: 23 · 2021: 19 · 2020: 16
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81700608, 81720108008, 2018YFC1312700)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- mitophagy, acute kidney injury, kidney repair, mitochondrial quality control, renal tubular epithelial cells, renal fibrosis, chronic kidney disease, autophagy, mitochondrial pathology, therapeutic target
- MeSH terms
- Animals, Autophagy, Humans, Kidney, Mitochondria, Models, Biological, Acute Kidney Injury, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.